Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celyad Sa ADR (NQ: CYAD )

1.830 UNCHANGED
Streaming Delayed Price Updated: 2:24 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 156
Open 1.830
Bid (Size) 1.730 (3)
Ask (Size) 1.870 (1)
Prev. Close 1.830
Today's Range 1.830 - 1.830
52wk Range 1.510 - 5.580
Shares Outstanding 22,593,956
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
71 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... 
Via Benzinga

Performance

YTD
-52.71%
-52.71%
1 Month
-16.82%
-16.82%
3 Month
-23.43%
-23.43%
6 Month
-51.97%
-51.97%
1 Year
-65.21%
-65.21%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Scheduled For March 24, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
FDA Slaps Clinical Hold On Celyad's Phase 1 Colorectal Cancer Trial
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Celyad Stops Early-Stage Colorectal Cancer Trial Amid Reported Fatalities
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
58 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks Eye Daily, Weekly Drops as Omicron Variant Spreads
Via Talk Markets
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
41 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
SWBI Stock: Why Smith & Wesson Shares Are Getting Gunned Down Today
Via InvestorPlace
Topics Firearms
Exposures Firearms
Hot Biotech Stocks: Why Celyad Oncology (CYAD) Is Soaring Higher Today
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.